Osaic Holdings
PLSE icon

Osaic Holdings’s Pulse Biosciences PLSE Stock Holding History

Osaic Holdings’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$53.7K Sell
1,936
-6
-0.3% -$142 ﹤0.01% 5429
2026
Q1 		$41.9K Buy
1,942
+21
+1% +$388 ﹤0.01% 5339
2025
Q4 		$26.4K Sell
1,921
-582
-23% -$9.07K ﹤0.01% 5674
2025
Q3 		$44.5K Sell
2,503
-4,489
-64% -$71K ﹤0.01% 5384
2025
Q2 		$106K Buy
6,992
+317
+5% +$5.26K ﹤0.01% 4463
2025
Q1 		$107K Buy
6,675
+1,559
+30% +$29.1K ﹤0.01% 4118
2024
Q4 		$89.1K Buy
5,116
+6
+0.1% +$106 ﹤0.01% 4269
2024
Q3 		$89.6K Hold
5,110
– – ﹤0.01% 4304
2024
Q2 		$57.2K Sell
5,110
-3,990
-44% -$37.6K ﹤0.01% 4579
2024
Q1 		$79.3K Sell
9,100
-35,095
-79% -$323K ﹤0.01% 4403
2023
Q4 		$541K Sell
44,195
-15,212
-26% -$105K ﹤0.01% 3099
2023
Q3 		$239K Buy
59,407
+425
+0.7% +$2.64K ﹤0.01% 3871
2023
Q2 		$424K Buy
58,982
+2,672
+5% +$17.1K ﹤0.01% 3285
2023
Q1 		$189K Sell
56,310
-11,000
-16% -$33.2K ﹤0.01% 3911
2022
Q4 		$187K Buy
67,310
+18,079
+37% +$40.6K ﹤0.01% 3915
2022
Q3 		$113K Buy
49,231
+21,975
+81% +$35.7K ﹤0.01% 4269
2022
Q2 		$41K Buy
27,256
+1,378
+5% +$3.46K ﹤0.01% 5106
2022
Q1 		$126K Buy
25,878
+5,265
+26% +$43.1K ﹤0.01% 4407
2021
Q4 		$306K Buy
20,613
+3,150
+18% +$62.7K ﹤0.01% 3546
2021
Q3 		$377K Buy
17,463
+4,140
+31% +$89.1K ﹤0.01% 3323
2021
Q2 		$219K Buy
13,323
+6,348
+91% +$121K ﹤0.01% 3796
2021
Q1 		$165K Buy
6,975
+200
+3% +$5.98K ﹤0.01% 3918
2020
Q4 		$161K Hold
6,775
– – ﹤0.01% 3668
2020
Q3 		$80K Hold
6,775
– – ﹤0.01% 3990
2020
Q2 		$71K Hold
6,775
– – ﹤0.01% 3931
2020
Q1 		$48K Buy
+6,775
New +$70.3K ﹤0.01% 3998

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Osaic Holdings's PLSE Position: Q2 2026 in Review

Osaic Holdings reduced its Pulse Biosciences (PLSE) stake by 0.31% in Q2 2026, selling an estimated $142 and leaving 1,936 shares worth $53.7K. The position accounts for ﹤0.01% of the portfolio, ranked #5429.

Osaic Holdings first reported a position in PLSE in Q1 2020 and has held it in 26 quarters since. The position peaked at $541K in Q4 2023. 106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • Osaic Holdings held 1,936 shares of Pulse Biosciences worth $53.7K as of Q2 2026.
  • Osaic Holdings sold 6 Pulse Biosciences shares in Q2 2026, an estimated $142.
  • Pulse Biosciences made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5429 holding.
  • Osaic Holdings first reported a position in Pulse Biosciences in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Pulse Biosciences position peaked at $541K in Q4 2023.
  • 106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.